Table 3 Descriptive statistics
Intervention Phase (Monthly Means & Sample Sizes) | ||||
|---|---|---|---|---|
New Counts of MOUD | ||||
| Â | Low Coaching | High Coaching | ||
| Â | ECHO | No ECHO | ECHO | No ECHO |
Buprenorphine | 3.00 | 17.43 | 21.79 | 5.01 |
(sd 4.05) | (sd 25.56) | (sd 28.5) | (sd 2.98) | |
n = 8 | n = 8 | n = 9 | N = 4 | |
Methadone | .55 | 2.03 | 20.36 | 4.47 |
(sd 1.57) | (sd 5.57) | (sd 51.31) | (sd 9.63) | |
n = 10 | n = 9 | n = 9 | n = 6 | |
Naltrexone | 0.33 | 1.37 | 0.19 | 0.44 |
(sd 0.42) | (sd 2.05) | (sd 0.28) | (sd 0.86) | |
n = 8 | n = 9 | n = 9 | n = 6 | |
Combined MOUD | 2.37 | 16.4 | 42.3 | 8.62 |
(sd 4.57) | (sd 30.3) | (sd 56.5) | (sd 10.6) | |
n = 10 | n = 10 | n = 9 | n = 6 | |
Census Counts of MOUD | ||||
| Â | Low Coaching | High Coaching | ||
| Â | ECHO | No ECHO | ECHO | No ECHO |
Buprenorphine | 117.62 | 60.57 | 104.07 | 36.50 |
(sd 190.42) | (sd 105.31) | (sd 145.32) | (sd 45.29) | |
n = 6 | n = 9 | n = 8 | n = 7 | |
Methadone | 0.08 | 0.94 | 98.73 | 56.58 |
(sd 0.25) | (sd 1.80) | (sd 216.36) | (sd 158.40) | |
n = 9 | n = 9 | n = 9 | n = 8 | |
Naltrexone | 2.60 | 3.21 | 0.24 | 5.81 |
(sd 5.29) | (sd 6.16) | (sd 0.34) | (sd 15.04) | |
n = 7 | n = 9 | n = 8 | n = 8 | |
Combined MOUD | 79.5 | 60.1 | 177 | 100 |
(sd 156) | (sd 105) | (sd 235) | (sd 207) | |
n = 10 | n = 9 | n = 9 | n = 8 | |